The levels of δRec-ψJα sjTRECs in PBMCs, CD3+, CD4+, and CD8+ T cells were significantly decreased in CML patients, compared with control groups. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.